Research Topics
Species | Kwok Leung CheungSummaryAffiliation: University of Nottingham Country: UK Publications
| Collaborators
|
Detail Information
Publications
Comprehensive geriatric assessment for older women with early breast cancer - a systematic review of literatureRuth M Parks
Division of Breast Surgery, University of Nottingham, Nottingham, UK
World J Surg Oncol 10:88. 2012..The Comprehensive Geriatric Assessment (CGA) is an analytical tool increasingly implemented in clinical practice. Breast cancer is primarily a disease of older people; however, most evidence-based research is aimed at younger patients...
Optimising the management of primary breast cancer in older women - a report of a multi-disciplinary study dayK L Cheung
Division of Breast Surgery, University of Nottingham, UK
Breast 20:581-4. 2011....
Clinical relevance of "withdrawal therapy" as a form of hormonal manipulation for breast cancerAmit Agrawal
Division of Breast Surgery, GEM School, University of Nottingham, Royal Derby Hospital, Derby DE22 3NE, UK
World J Surg Oncol 9:101. 2011..However, evidence is scarce when this is extrapolated into clinical context. We report our experience to verify the clinical relevance of "withdrawal therapy"...
The use of fulvestrant, a parenteral endocrine agent, in intestinal obstruction due to metastatic lobular breast carcinomaJasmine Y M Tang
Division of Breast Surgery, University of Nottingham, Nottingham, UK
World J Surg Oncol 6:128. 2008..The role of fulvestrant in the management of intestinal obstruction associated with lobular carcinoma has not been specifically described...
A paraneoplastic manifestation of metastatic breast cancer responding to endocrine therapy: a case reportJoanna P Wood
Department of Medical Oncology, City Hospital, Nottingham University Hospitals NHS Trust, Nottingham, UK
World J Surg Oncol 6:132. 2008..These syndromes are usually treated by chemotherapy with or without immunosupression but they often respond poorly. There are no published reviews on response to endocrine treatment...
Ruptured gallbladder as the first presentation of breast cancerM Jones
Professorial Unit of Surgery, City Hospital, Nottingham, UK
World J Surg Oncol 7:50. 2009..Perforation of the gall bladder as a first presentation of breast cancer has not been reported...
Serum epidermal growth factor receptor and HER2 expression in primary and metastatic breast cancer patientsKristjan S Asgeirsson
Division of Breast Surgery, University of Nottingham, Nottingham City Hospital, Hucknall Road, Nottingham NG5 1PB, UK
Breast Cancer Res 9:R75. 2007..The clinical relevance of this has not been fully established...
Endocrine therapy for breast cancer: an overviewK L Cheung
Division of Breast Surgery, University of Nottingham, City Hospital, Hucknall Road, Nottingham NG5 1PB, UK
Breast 16:327-43. 2007..Ongoing and future studies will optimise treatment in established areas and will exploit its potential roles in preoperative use and chemoprevention...
Endocrine response after prior treatment with fulvestrant in postmenopausal women with advanced breast cancer: experience from a single centreK L Cheung
Division of Breast Surgery, University of Nottingham, Nottingham City Hospital, Hucknall Road, Nottingham NG5 1PB, UK
Endocr Relat Cancer 13:251-5. 2006..It would thus appear that further endocrine response can be induced in a reasonable proportion of patients after failing fulvestrant...
The use of blood tumour markers in the monitoring of metastatic breast cancer unassessable for response to systemic therapyK L Cheung
Department of Surgery, City Hospital, Nottingham, United Kingdom
Breast Cancer Res Treat 67:273-8. 2001..5 months. Biochemical assessment by blood tumour markers is useful in patients with metastatic breast cancer unassessable for response to systemic therapy. These findings need to be confirmed in a larger patient series...
Pathological features of primary breast cancer in the elderly based on needle core biopsies--a large series from a single centreK L Cheung
Division of Breast Surgery, University of Nottingham, UK
Crit Rev Oncol Hematol 67:263-7. 2008..We have clearly confirmed the high frequency of ER-positive tumours in elderly patients. Further work is underway to assess long-term outcome and clinical relevance...
Bony metastases from breast cancer - a study of foetal antigen 2 as a blood tumour markerKwok Leung Cheung
Division of Breast Surgery, University of Nottingham, Nottingham, UK
World J Surg Oncol 8:38. 2010..Serum concentrations of FA-2 appeared to be elevated in a number of disorders of bone metabolism. This paper is the first report of its role as a marker of bone metabolism in metastatic breast cancer...
FulvestrantKwok Leung Cheung
Professorial Unit of Surgery, Nottingham City Hospital, Hucknall Road, Nottingham NG5 1PB, UK
Expert Opin Investig Drugs 11:303-8. 2002..With the role of tamoxifen as the gold standard of first-line therapy being challenged by the third generation aromatase inhibitors, direct comparison of the latter with fulvestrant in the first-line setting may also be worthwhile...
Approach to a lump in the breast: a regional perspectiveKwok Leung Cheung
Professorial Unit of Surgery, Nottingham City Hospital, Hucknall Road, Nottingham NG5 1PB, U K
Asian J Surg 28:65-70. 2005..This article discusses the clinical assessment and investigation of breast lumps and possible treatments from an Asia Pacific perspective...
Objective measurement of remission and progression in metastatic breast cancer by the use of serum tumour markersK L Cheung
Professorial Unit of Surgery, Nottingham City Hospital, UK
Minerva Chir 58:297-303. 2003..Future studies should aim at incorporating new markers (e.g. serum c-erbB2, markers of bone metabolism) to tailor different clinical situations, and at exploiting the use of serum markers to direct systemic therapy...
Suppression of ovarian function in combination with an aromatase inhibitor as treatment for advanced breast cancer in pre-menopausal womenK L Cheung
Division of Breast Surgery, University of Nottingham, UK
Eur J Cancer 46:2936-42. 2010..Within the limitations of being a non-randomised study, they should be considered in appropriate patients with hormone-sensitive ABC...
Primary endocrine therapy in locally advanced breast cancers--the Nottingham experienceJ Mathew
Division of Breast Surgery, University of Nottingham, Nottingham, UK
Breast Cancer Res Treat 113:403-7. 2009..We report our experience of primary endocrine therapy in ER+ LAPC...
Successful management of elderly breast cancer patients treated without radiotherapyKalliope Valassiadou
Division of Breast Surgery, University of Nottingham, Nottingham, UK
World J Surg Oncol 5:62. 2007..The addition of RT to surgery might constitute an imposition to such patients due to age-related factors. The aim of this study was to assess the efficacy of BCS without adjuvant RT in this group of patients...
Clinical and endocrine data for goserelin plus anastrozole as second-line endocrine therapy for premenopausal advanced breast cancerD P Forward
Professorial Unit of Surgery, City Hospital, Hucknall Road, Nottingham NG5 1PB, UK
Br J Cancer 90:590-4. 2004..Further studies involving more patients and longer follow-up are indicated...
Bone metastases from breast carcinoma: histopathological - radiological correlations and prognostic featuresJ J James
Nottingham City Hospital, Hucknall Road, Nottingham NG5 1PB, UK
Br J Cancer 89:660-5. 2003....
Biological profile of oestrogen receptor positive primary breast cancers in the elderly and response to primary endocrine therapyG Okunade
Division of Breast Surgery, Nottingham University Hospitals, City Hospital Campus, Nottingham, NG5 1PB, UK
Crit Rev Oncol Hematol 72:76-82. 2009..In this population, ERalpha+ breast cancer also appears to have a less aggressive biological profile favouring better hormone sensitivity...
The reliability of assessment of oestrogen receptor expression on needle core biopsy specimens of invasive carcinomas of the breastZsolt Hodi
Departments of Histopathology and Surgery, Nottingham City Hospital, UK
J Clin Pathol 60:299-302. 2007..To assess the reliability of assessment of oestrogen receptor expression on needle core biopsy specimens of invasive carcinomas of the breast. Previous studies have mostly been small, with a range of agreement from 62% to 100%...
Strength of ER-positivity in relation to survival in ER-positive breast cancer treated by adjuvant tamoxifen as sole systemic therapyDavid A L Morgan
Department of Clinical Oncology, Nottingham University Hospitals, City Campus, Nottingham, UK
Breast 20:215-9. 2011....
Neoadjuvant endocrine treatment in primary breast cancer - review of literatureJ Mathew
Division of Breast Surgery, Nottingham City Hospital, Nottingham, UK
Breast 18:339-44. 2009..Our review highlights the superiority of aromatase inhibitors over tamoxifen in the neoadjuvant setting and even challenges chemotherapy with regard to response in selected group of patients...
Fulvestrant - a novel endocrine therapy for breast cancerS J Johnston
University of Nottingham, Nottingham University Hospitals, Nottingham, UK
Curr Med Chem 17:902-14. 2010....
Neoadjuvant chemotherapy for locally advanced breast cancer: a review of the literature and future directionsJ Mathew
Professorial Unit of Surgery, Nottingham University Hospital, Nottingham, UK
Eur J Surg Oncol 35:113-22. 2009..Significant improvements in local disease control have been seen with recent advances in systemic chemotherapy regimens although thus far this has not shown in randomised trials to translate into overall survival benefits...
The role of blood tumor marker measurement (using a biochemical index score and c-erbB2) in directing chemotherapy in metastatic breast cancerK L Cheung
Department of Surgery, City Hospital, Nottingham, UK
Int J Biol Markers 15:203-9. 2000..003). Among the patients with positive tissue staining, sequential changes in serum c-erbB2 completely paralleled initial response...
Management of cyclical mastalgia in oriental women: pioneer experience of using gamolenic acid (Efamast) in AsiaK L Cheung
Department of Surgery, The University of Hong Kong, Queen Mary Hospital and Tung Wah Hospital
Aust N Z J Surg 69:492-4. 1999..In most Western countries gamolenic acid is the first-line treatment for women with cyclical mastalgia...
Selection of primary breast cancer patients for adjuvant endocrine therapy--is oestrogen receptor alone adequate?K L Cheung
Professorial Unit of Surgery, City Hospital, Nottingham, UK
Breast Cancer Res Treat 65:155-62. 2001..Further studies to elucidate other possible factors are warranted to refine the use of endocrine therapy, especially in the adjuvant setting when no indication of response is available...
Locally advanced primary breast cancer: medium-term results of a randomised trial of multimodal therapy versus initial hormone therapyS M Tan
Department of Surgery, City Hospital, Nottingham, UK
Eur J Cancer 37:2331-8. 2001..Thus, initial hormone therapy may be a reasonable option for managing locally advanced primary breast cancer, especially for oestrogen receptor-positive tumours...
Early primary breast cancer in the elderly - pattern of presentation and treatmentS W Tang
Division of Breast Surgery, City Hospital, Hucknall Road, University of Nottingham, Nottingham NG5 1PB, UK
Surg Oncol 20:7-12. 2011..This study aimed to identify a profile of characteristics in elderly women with operable primary breast cancer and investigate the dynamics influencing the treatment decision-making process...
Metastatic carcinoma of the breast with tubular features: differences compared with metastatic ductal carcinoma of no specific typeL J Hamilton
Nottingham Breast Institute, Nottingham City Hospital, Nottingham, UK
Clin Oncol (R Coll Radiol) 16:119-24. 2004..This improved survival can be explained by better well-recognised prognostic features, such as metastatic site pattern, histological grade, ER status and disease-free interval...
Brain metastases from breast cancer: identification of a high-risk groupA J Evans
Nottingham Breast Institute, City Hospital, Nottingham, UK
Clin Oncol (R Coll Radiol) 16:345-9. 2004....
Neoadjuvant chemotherapy in locally advanced primary breast cancers: the Nottingham experienceJ Mathew
Professorial Unit of Surgery, Nottingham City Hospital, Hucknall Road, Nottingham, UK
Eur J Surg Oncol 33:972-6. 2007....
Bone turnover markers in postmenopausal breast cancer treated with fulvestrant--a pilot studyA Agrawal
University of Nottingham, Professorial Unit of Surgery, City Hospital Campus, Nottingham University Hospitals, Hucknall Road, Nottingham NG5 1PB, UK
Breast 18:204-7. 2009..Tamoxifen has a protective effect on bone metabolism in breast cancer; aromatase inhibitors deleterious and that of fulvestrant is unknown...
Concepts of seroma formation and prevention in breast cancer surgeryAmit Agrawal
Professorial Unit of Surgery, Nottingham City Hospital, Nottingham, UK
ANZ J Surg 76:1088-95. 2006..Low-pressure suction drainage reduces seroma volume and duration of drainage leading to earlier drain removal. Preventive measures have to be tailored according to individual patient and operative factors...
Patterns of metastatic breast carcinoma: influence of tumour histological gradeG J R Porter
Helen Garrod Breast Unit, Nottingham City Hospitals NHS Trust, Nottingham, UK
Clin Radiol 59:1094-8. 2004..This finding may also prove useful in interpreting imaging in patients who have a history of breast cancer and undergo subsequent imaging because of new symptoms...
Is surgery always indicated in older women with breast cancer?S W Tang
Division of Breast Surgery, University of Nottingham, Nottingham, UK
Minerva Chir 65:555-68. 2010..A dedicated multidisciplinary-led clinic may provide a suitable platform for the assessment, review and management of this distinctive set of patients...
Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? A prospective studyA R Bristow
Division of Breast Surgery, University of Nottingham, UK
Breast 17:98-103. 2008..The aim of this study was to determine whether bone scans (BS) can be avoided if pelvis was included in CT thorax and abdomen to detect bony metastases from breast cancer...
